About Gmedica

According to Merrill Lynch, diagnostic tools related to electrophysiology are estimated at $740 million. The market is anticipated to continue strong growth over the next decade.

GMedica has identified a growing demand for software and devices that facilitate efficient, non-invasive diagnostic testing and monitoring. The GMedica technology combines proprietary signal processing and pattern detection algorithms in a device that improves the sensitivity and specificity of cardiovascular diagnostic and monitoring systems.

The non-invasive technology results in fast, reliable and accurate results.